Striving for an effective but parsimonious use of sedation in pediatric intensive care by Vet, N.J. (Nienke) et al.
Intensive Care Med (2016) 42:1103–1104
DOI 10.1007/s00134-016-4334-3
CORRESPONDENCE
Striving for an effective 
but parsimonious use of sedation  
in pediatric intensive care
Nienke J. Vet* , Saskia N. de Wildt, Dick Tibboel and Matthijs de Hoog
© 2016 Springer-Verlag Berlin Heidelberg and ESICM 
Dear Editor,
We greatly appreciate the interest shown in our paper 
by Zimmerman and colleagues [1].
First of all, we acknowledge that the secondary mor-
tality finding might have received more emphasis than 
warranted by the results of extensive causality analy-
sis. Indeed, we also believe that it is highly unlikely that 
there is a relationship between the causes of death and 
daily sedation interruption (DSI) [2]. Nevertheless, as 
this finding was totally unexpected, it was reported in all 
openness in the conclusion of the study.
In answer to the questions raised, our sedation proto-
col includes a weaning strategy, in which the nurse can 
actively taper the sedation. COMFORT-B scores are 
performed at least every 8 h and if lower than targeted, 
nurses can decrease the morphine and midazolam step-
wise. Morphine can be decreased by 10  mcg/kg/h once 
a day and midazolam by 50 mcg/kg/h every 8 h. In addi-
tion to the assessment of the COMFORT-B score, the 
validated numeric rating scale (NRS), the Sophia Obser-
vation withdrawal Symptoms (SOS), and SOS-pediatric 
delirium (SOS-PD) scale are standardly used in our PICU 
[3]. Together, these scores help to differentiate between 
distress, pain, withdrawal, and/or delirium. In addi-
tion, before increasing sedatives, nurses evaluate if a 
non-pharmacological intervention is effective to reduce 
distress.
We acknowledge that in many PICUs morphine is used 
as the first-line analgo-sedative drug, with the potential 
advantage of also providing analgesia. In our center, 
midazolam is used as the first-line sedative on the basis of 
the rationale that ICU treatment in itself is not so painful 
to warrant an opioid. Only when sedation is insufficient 
with midazolam will morphine be added, or when scores 
or clinical situation suggests pain. We are well aware of 
the risk of development of withdrawal and delirium after 
use of benzodiazepines, but data support that this is simi-
larly prevalent with opioids [4].
Further, although we did not explicitly study the 
immune competency status, we have no reason to believe 
that there would be a difference between both groups. 
Diagnoses were similar between both groups and most 
patients (67 %) were admitted for a respiratory disorder, 
mainly a viral pneumonia. Reintubations were more fre-
quent in the control group. Although the study was not 
completely blinded, to our own surprise, nurses and doc-
tors found the study protocol quite complicated and only 
seldom concluded study group allocation from the infu-
sion restart rate. Therefore, we believe that the risk of 
bias was minimized.
We agree that there is an increasing body of evidence 
for “less is more” in critical care, which the results of our 
study do not contradict. In lieu of the obvious unwanted 
effects of sedation, striving for an effective but parsimoni-
ous use of sedation in pediatric intensive care is impera-
tive. This should be the objective of future, well-designed 
multicenter randomized controlled trials (RCT). A 
potential future RCT could compare continuous ‘light 
sedation’ with ‘normal/conscious’ sedation. This may 
result in less variation in sedation levels with less extra 
boluses throughout the day, as compared to DSI, and a 
reduced cumulative need for sedative drug doses in the 
‘light sedation’ group.
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